DK0989858T3 - CD28/CTLA-4-inhiberende peptidomimetika og farmaceutiske præparater deraf - Google Patents

CD28/CTLA-4-inhiberende peptidomimetika og farmaceutiske præparater deraf

Info

Publication number
DK0989858T3
DK0989858T3 DK98929048T DK98929048T DK0989858T3 DK 0989858 T3 DK0989858 T3 DK 0989858T3 DK 98929048 T DK98929048 T DK 98929048T DK 98929048 T DK98929048 T DK 98929048T DK 0989858 T3 DK0989858 T3 DK 0989858T3
Authority
DK
Denmark
Prior art keywords
ctla
pharmaceutical compositions
peptidomimetics
inhibitory
interaction
Prior art date
Application number
DK98929048T
Other languages
English (en)
Inventor
Tayar Nabil El
Steven Blechner
Brad Jameson
Mark Tepper
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0989858T3 publication Critical patent/DK0989858T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70521CD28, CD152
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98929048T 1997-06-12 1998-06-11 CD28/CTLA-4-inhiberende peptidomimetika og farmaceutiske præparater deraf DK0989858T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4947097P 1997-06-12 1997-06-12
PCT/US1998/012312 WO1998056401A1 (en) 1997-06-12 1998-06-11 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same

Publications (1)

Publication Number Publication Date
DK0989858T3 true DK0989858T3 (da) 2004-08-09

Family

ID=21959997

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98929048T DK0989858T3 (da) 1997-06-12 1998-06-11 CD28/CTLA-4-inhiberende peptidomimetika og farmaceutiske præparater deraf

Country Status (12)

Country Link
US (1) US6337316B1 (da)
EP (1) EP0989858B1 (da)
JP (2) JP2002505673A (da)
AT (1) ATE264688T1 (da)
AU (1) AU743939B2 (da)
CA (1) CA2293666A1 (da)
DE (1) DE69823352T2 (da)
DK (1) DK0989858T3 (da)
ES (1) ES2215306T3 (da)
IL (2) IL133467A0 (da)
PT (1) PT989858E (da)
WO (1) WO1998056401A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3107699A (en) * 1998-03-19 1999-10-11 Heska Corporation Novel forms of t cell costimulatory proteins, nucleic acid molecules, and uses thereof
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ailimに対するヒトモノクローナル抗体及びその医薬用途
US7531168B2 (en) 2001-02-16 2009-05-12 Genetics Institute Llc Method for downmodulating immune response in type I diabetes
IL148993A0 (en) * 2002-04-04 2002-11-10 Yissum Res Dev Co Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
WO2004087754A1 (en) * 2003-04-03 2004-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
US8535672B2 (en) * 2002-04-04 2013-09-17 Yissum Research Development Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
WO2004081021A2 (en) * 2003-03-12 2004-09-23 Duke University Oligonucleotide mimetics
US20060075968A1 (en) * 2004-10-12 2006-04-13 Applied Materials, Inc. Leak detector and process gas monitor
US7892827B2 (en) 2004-11-26 2011-02-22 Pieris Ag Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
WO2008083169A2 (en) 2006-12-26 2008-07-10 The Johns Hopkins University Compositions and methods for the treatment of immunologic disorders
US20090007853A1 (en) * 2007-07-03 2009-01-08 Tyson Foods, Inc. Stackable tray system and method to load, transport, stun and singulate poultry
EP2646552B1 (en) 2010-12-02 2017-07-05 Pieris Pharmaceuticals GmbH Muteins of human lipocalin 2 with affinity for ctla-4
EP2997373A1 (en) 2013-05-17 2016-03-23 MedImmune, LLC Receptors for b7-h4
CA2936611A1 (en) 2014-01-13 2015-07-16 Pieris Pharmaceuticals Gmbh Multi-specific polypeptide useful for localized tumor immunomodulation
US20170355755A1 (en) 2014-11-21 2017-12-14 Yale University Compositions and methods for modulating salm5 and hvem
WO2018083080A2 (en) 2016-11-04 2018-05-11 Innate Pharma Nkp46 ligand
IT201800004853A1 (it) 2018-04-24 2019-10-24 Metodi per trattare il cancro
JP7498889B2 (ja) 2020-01-30 2024-06-13 東亞合成株式会社 Ctla4とb7タンパク質との結合を抑制するペプチドおよびその利用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192746A (en) * 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
CA2580812A1 (en) * 1991-06-27 1993-01-07 Bristol-Myers Squibb Company Ctla4 receptor, fusion proteins containing it and uses thereof
US5773253A (en) * 1993-01-22 1998-06-30 Bristol-Myers Squibb Company MYPPPY variants of CTL A4 and uses thereof
US5888763A (en) * 1994-12-30 1999-03-30 The Rockefeller University Peptides specific for the first Crk-SH3 domain
WO1996031229A1 (en) * 1995-04-05 1996-10-10 Beth Israel Hospital Association Inhibiting rejection of a graft

Also Published As

Publication number Publication date
AU743939B2 (en) 2002-02-07
JP2009029833A (ja) 2009-02-12
ES2215306T3 (es) 2004-10-01
DE69823352D1 (de) 2004-05-27
EP0989858A4 (en) 2001-03-21
DE69823352T2 (de) 2004-09-02
IL133467A0 (en) 2001-04-30
PT989858E (pt) 2004-07-30
IL133467A (en) 2006-12-31
JP2002505673A (ja) 2002-02-19
EP0989858A1 (en) 2000-04-05
WO1998056401A1 (en) 1998-12-17
CA2293666A1 (en) 1998-12-17
US6337316B1 (en) 2002-01-08
EP0989858B1 (en) 2004-04-21
AU8070698A (en) 1998-12-30
ATE264688T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
DK0989858T3 (da) CD28/CTLA-4-inhiberende peptidomimetika og farmaceutiske præparater deraf
HU9300282D0 (en) Compounds and method for inhibiting gene expression
MX343744B (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
MX9804263A (es) Expresion de genes incrementada por intensificador en plantas.
DE60121808D1 (de) Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
ATE440863T1 (de) Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhíhung von einer entzündungsreaktion
DE69834267D1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
MY138258A (en) Growth hormone secretagogues
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
EP1037999A4 (en) POLYPEPTIDES AND NUCLEOTIDES PORPHYROMONAS GINGIVALIS
MY120024A (en) Process for preparation of eprosartan using regioselective protection of 2,4-disubstituted-imidazole intermediates.
DE69526087D1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
ATE318910T1 (de) Cholesterinoxidase aus brevibacterium sterolicum
DK0469523T3 (da) Kloning og overekspression af glucose-6-phosphatdehydrogenase fra Leuconostoc dextranicus
WO1999028449A3 (en) Yac vectors
MX9603991A (es) Peptidos para inhibir la liberacion de pepsina.
NO930358L (no) Forbindelser og fremgagsmaater for inhibering av genekspresjon
MX9708943A (es) Genes de polifenol oxidasa de la lengua y platano.